Status:
ACTIVE_NOT_RECRUITING
The Sleep2BWell Trial
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Weill Medical College of Cornell University
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Blood Pressure
Sleep Health
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Improving multiple domains of cardiometabolic health (CMH) through contextual behavioral interventions has the potential to substantially reduce persistent chronic disease disparities. Sleep is critic...
Eligibility Criteria
Inclusion
- English- and/or Spanish-speaking
- aged ≥20 years
- having at minimum SBP in the elevated or hypertension category (i.e., SBP ≥120 mmHg)
Exclusion
- No known medical conditions that would prevent them from safely participating in the trial (e.g., neurological degenerative disease such as Parkinsons, severe psychiatric disorders, substance use disorder)
- History of cardiovascular disease or cancer
- Pregnant or desire to become pregnant during the study
- Less than one year postpartum
Key Trial Info
Start Date :
January 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06565104
Start Date
January 25 2025
End Date
March 1 2026
Last Update
April 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10021
2
Columbia University Irving Medical Center, Mailman School of Public Health
New York, New York, United States, 10032